FMA
ONCS

FNY Managed Accounts’s OncoSec Medical Incorporated ONCS Stock Holding History

FNY Managed Accounts’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9K Hold
23
– – 0.01% 164
2017
Q4 		$8K Buy
+23
New +$8.06K 0.01% 256

Other funds holding ONCS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Managed Accounts's ONCS Position: Q1 2018 in Review

FNY Managed Accounts held its OncoSec Medical Incorporated (ONCS) position steady in Q1 2018 at 23 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #164.

FNY Managed Accounts first reported a position in ONCS in Q4 2017 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold ONCS as of Q1 2018.

  • FNY Managed Accounts held 23 shares of OncoSec Medical Incorporated worth $9K as of Q1 2018.
  • FNY Managed Accounts left its OncoSec Medical Incorporated share count unchanged in Q1 2018.
  • OncoSec Medical Incorporated made up 0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #164 holding.
  • FNY Managed Accounts first reported a position in OncoSec Medical Incorporated in Q4 2017 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.